CreditReports.dk
HomeScreen companies

MC2 Therapeutics A/S Financials, key figures and credit report

CVR number: 29526346 Established 2006 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Agern Alle 24-26, 2970 Hørsholm tel: 53514153
Gross profit 22 248.5 kDKK FY 2025 -9.2% vs 2024
EBIT 1 149.2 kDKK FY 2025 -0.6% vs 2024
Net debt 275 401.6 kDKK FY 2025 +0.9% vs 2024
Quick ratio 1.0 FY 2025 -2.7 vs 2024

Company information

Official name
MC2 Therapeutics A/S
Personnel
11 persons
Established
2006
Company form
Limited company
Industry

Data sources and methodology

The information about MC2 Therapeutics A/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About MC2 Therapeutics A/S

MC2 Therapeutics A/S (CVR number: 2952634-6) is a company from RUDERSDAL. The company recorded a gross profit of 22.2 mDKK in 2025. The operating profit was 1149.2 kDKK, while net earnings were -7817 kDKK. The profitability of the company measured by Return on Assets (ROA) was 8.8 %, which can be considered good but Return on Equity (ROE) was -12.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -79.9 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. MC2 Therapeutics A/S's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit27 734.4424 451.6326 355.1824 493.4222 248.50
EBIT1 451.911 627.571 669.551 156.611 149.22
Net earnings-25 222.96- 101 331.26-41 851.17-53 006.93-7 816.95
Shareholders equity total-21 097.59- 122 649.95- 164 533.85- 218 391.02- 224 478.93
Balance sheet total (assets)51 602.5138 592.3430 588.6964 386.3356 366.08
Net debt65 790.13156 752.93190 139.03273 065.04275 401.58
Profitability
EBIT-%
ROA-40.5 %-79.5 %-12.7 %-9.9 %8.8 %
ROE-77.0 %- 224.7 %- 121.0 %- 111.6 %-12.9 %
ROI-44.9 %-82.8 %-13.0 %-10.0 %8.9 %
Economic value added (EVA)-97.96- 691.88-84.71- 176.58-1 953.13
Solvency
Equity ratio-29.0 %-76.1 %-84.3 %-77.2 %-79.9 %
Gearing- 318.8 %- 128.5 %- 116.1 %- 128.3 %- 123.5 %
Relative net indebtedness %
Liquidity
Quick ratio0.13.03.93.71.0
Current ratio0.13.03.93.71.0
Cash and cash equivalents1 465.82807.69925.997 064.301 867.11
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
8.76%
Rating 54/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
-79.9%
Rating 0/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of MC2 Therapeutics A/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated